
NBE-Therapeutics is a privately owned Swiss, Basel-based Biotech company that was founded in 2012 with the vision to develop next-generation ADCs improving treatment options for cancer patients. The company is financially backed by the Boehringer Ingelheim Venture Fund and additional private investors.
It is NBE Therapeutics vision to become a leader in antibody-based drug development by developing its own portfolio of drugs until demonstration of a clinical proof-of-concept in man.
Developer of antibody based drugs. The company engages in providing antibody drug conjugates for the treatment of cancer.

Sagen Sie NBE Therapeutics, dass Sie interessiert sind dort zu arbeiten, ihre persönlichen Informationen bleiben dabei anonym. Comparably gibt NBE Therapeutics die Gelegenheit, Sie anzustellen. Wenn es eine passende Stelle gibt, matchen wir diese.
Senden Sie ihnen eine Einladung, um die Unternehmenskultur zu bewerten.